These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1643465)

  • 1. Vanishing bile duct syndrome.
    Burra P; Elias E
    Br J Surg; 1992 Jul; 79(7):604-5. PubMed ID: 1643465
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis.
    Wiegand J; Neid M; Kaiser T; Wittekind C; Mössner J; Tillmann HL; Schiefke I
    Z Gastroenterol; 2006 Dec; 44(12):1227-9. PubMed ID: 17163373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis].
    Mandera M; Nowakowska-Duława E; Hartleb M
    Wiad Lek; 1992 May; 45(9-10):366-70. PubMed ID: 1441546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destructive intrahepatic bile duct diseases.
    Desmet VJ
    Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis.
    Nakanuma Y; Ohta G; Yamazaki Y; Doishita K
    Acta Pathol Jpn; 1979 Mar; 29(2):211-9. PubMed ID: 552794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa.
    Goritsas CP; Repanti M; Papadaki E; Lazarou N; Andonopoulos AP
    J Hepatol; 1997 Mar; 26(3):727-30. PubMed ID: 9075683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of chronic cholestasis and adult ductopenic syndrome.
    Desmet VJ
    Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.
    Forbes GM; Jeffrey GP; Shilkin KB; Reed WD
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1385-8. PubMed ID: 1551543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of intrahepatic cholestasis syndrome].
    Kraus MR; Scheurlen M
    MMW Fortschr Med; 2004 Jun; 146(23):34-7. PubMed ID: 15373130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
    Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
    Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
    Kochar R; Nevah MI; Lukens FJ; Fallon MB; Machicao VI
    World J Gastroenterol; 2010 Jul; 16(26):3335-8. PubMed ID: 20614492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
    Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
    J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.